Globenewswire

搜索文档
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
Globenewswire· 2025-10-01 12:00
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the initiation of toxicology studies conducted under Good Laboratory Practice (GLP) standards for its lead product candidate, CMP-S ...
SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee
Globenewswire· 2025-10-01 12:00
TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” ...
Integral Metals Corp. Provides Comprehensive Analysis of Soil Geochemical Survey at the KAP Project
Globenewswire· 2025-10-01 12:00
Over 2,000 soils analyzed; 818 B-horizon samples returned multiple anomalies with scores up to 11CALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to report the completion and compilation of its 2025 soil geochemistry survey at the KAP Project, located in the Mackenzie Mountains, Northwest Territories. The program was designed to systematically evaluate near-surface geochemical responses in the vicinity of t ...
Asia Broadband Finalizes Milestone Production Agreement For Second Large-Scale Gold and Silver Ore Stockpile in Mexico
Globenewswire· 2025-10-01 12:00
LAS VEGAS, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has finalized the terms of another historic and long-term processing and production agreement for a large-scale gold and silver ore stockpile in Etzatlan, Jalisco, Mexico. The estimated gold and silver ore value of this second stockpile agreement exceeds the value of the Company’s first stockpile agreement completed in December 2022. AABB management is thrilled to re ...
Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors
Globenewswire· 2025-10-01 12:00
Plans to reach nearly 8.3 million Medicare-eligible adults across five states during annual enrollment period, Oct. 15-Dec. 7ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68 plan options across 45 counties in five states. The plans are designed to deliver consistent value, broad coverage and support for seniors’ diverse health needs. Medicare’s annual enrollmen ...
Aeries Technology Delivers ~30% Faster Development Cycles Through AI-Enabled Engineering
Globenewswire· 2025-10-01 12:00
AI-led application modernization drives client-wide expansion interest, supports repeatable engineering transformation playbookNEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, today announced the successful completion of an AI-driven application modernization engagement with a high-transaction digital platform provider. Aeries deployed AI-based software development and testin ...
Global Uranium Corp. Announces Plans for Fieldwork in Wyoming, USA
Globenewswire· 2025-10-01 12:00
Initial Field Program to Assess Radiometric Trends and Identify High-Priority Uranium TargetsCALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the “Company”) is pleased to announce its intention to initiate fieldwork on the Airline Project, located in the Copper Mountain District of Wyoming. The program will be designed to advance the Company’s understanding of surface radiometric signatures and provide the foundation for follow-up exploration. The ...
Abacus Asset Group to Host Investor Summit on Longevity-Based Investments and Private Credit in Zurich, Switzerland with Global Virtual Access
Globenewswire· 2025-10-01 12:00
ORLANDO, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL), a leader in the alternative asset management space, announced today that its specialized division, Abacus Asset Group, will host an Investor Summit on Tuesday, October 28, 2025, at The Dolder Grand in Zurich, Switzerland. The event will highlight the secondary life insurance industry, lifespan-based financial products, and private credit opportunities, offering both in-person and virtua ...
VirTra Training Simulators Validated and Set to Deploy with Royal Canadian Mounted Police
Globenewswire· 2025-10-01 12:00
CHANDLER, Ariz., Oct. 01, 2025 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use- of- force training simulators and firearms training simulators for the law enforcement and military markets, today announced that the Royal Canadian Mounted Police (RCMP) has advanced to full deployment of 20 previously purchased VirTra training simulators following successful field testing and validation at its training depot in Regina. The 20 training systems wer ...
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
Globenewswire· 2025-10-01 12:00
- Meeting date aligns with prior guidance - - FDA to review AEON’s analytical development plan and initial data - IRVINE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a biopharmaceutical company developing ABP-450 (prabotulinumtoxinA) as a BOTOX® (onabotulinumtoxinA) biosimilar, today announced that the U.S. Food and Drug Administration (FDA) has scheduled a Biosimilar Biological Product Development (BPD) Type 2a meeting for ABP-450 on November 19, 2 ...